| Today's Open | $105.10 |
|---|---|
| Previous Close | $105.62 |
| Daily Range | $104.37 - $106.03 |
| 52-Week Range | $67.61 - $114.95 |
| Market Cap | $79.2B |
| P/E Ratio | 17.84 |
| Dividend (Yield) | $1.88 (1.8%) |
| Ex-Dividend Date Dividend Pay Date |
05/14/13 06/07/13 |
| Volume | 1,297,492 |
| Average Daily Volume | 3,969,320 |
| Current FY EPS | $7.19 |
Sector
Healthcare
Industry
Drugs
Amgen, Inc. (AMGN) Description
A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/
News & Commentary
How is one of the pioneers of biotech doing lately? Find out in this month's Amgen stock checkup.
Oncolytics announces successful tests for cancer drug Reolysin.
Can Financial Innovation Unlock a Cure for Cancer?
Andrew W. Lo from the MIT Sloan School of Management has a rather Foolish idea for solving the world's biggest problems.AMGN's Top Competitors
(0.04%)
(0.70%)
(-0.99%)
